Delivery Order SPE2DB20D3103-SPE2DB25FP8M1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,325.64 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 10 gram/100 mL immunoglobulin vial product, with an ultimate completion date of August 21, 2025. This competitive award, issued on July 31, 2025, utilizes a firm fixed price contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Gamunex-C 5 gram/50 ml vials valued at $1,518.35, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a potential value of $999,999,999 and...
- The Defense Logistics Agency awarded a delivery order valued at $3,036.70 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 5 gram/50 milliliter vials. This firm fixed-price contract, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $34,908 on July 24, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, reflecting AmerisourceBergen's demonstrated capability to compete in the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of Gamunex-C 40 gram/400 mL vials. The contract, valued at $46,544.00, carries a firm fixed price structure with an ultimate completion date of September 5, 2025. This award represents a non-set-aside competitive procurement and will be performed at the contractor's Conshohocken facility. The...
- The Defense Logistics Agency awarded a $40,532.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials, with an ultimate completion date of August 22, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a $28,323.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials with an ultimate completion date of August 22, 2025. This non-set-aside competitive award was issued on August 1, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Gamunex-C 1 gram/10 milliliter vials with a ceiling value of $1,223.80 and a completion date of September 3, 2025. This non-set-aside, firm fixed-price delivery order represents a competitively awarded contract under the company's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion through December...
- The Defense Logistics Agency awarded a delivery order valued at $84,970.08 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 20 gram/200 mL vials with a completion date of September 3, 2025. This firm fixed-price delivery order, awarded on August 12, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location...
- The Defense Logistics Agency awarded a $7,080.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials with a completion date of August 28, 2025. This non-set-aside award was issued on August 7, 2025, and represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing contract vehicle with DLA. The product will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8M1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,591.75 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 5 gram/50 mL vials on August 12, 2025. This competitive award, issued without set-aside designation, is structured as a firm fixed price delivery order with an ultimate completion date of September 3, 2025. The products will be delivered to the place of performance located in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters. This delivery order represents a child contract action under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen functions as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to support military healthcare systems and the Defense Health Agency. The company's extensive federal contracting history demonstrates consistent competitively-awarded delivery orders for specialized pharmaceuticals and medical commodities across multiple therapeutic domains, positioning it as a key vendor for DoD pharmaceutical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/12/25 |